Paula Marques Marinho

Paula Marques Marinho

Auto-generated profile, based on publicly available information

Paula Marques Marinho

São Paulo Hospital, Paulista School of Medicine, Federal University of São Paulo, Sao Paulo, Brazil

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in The Lancet
Verified
Journal Article
Closed access
PMPaula M Marinho
Paula M Marinho
AMAllexya A A Marcos
Allexya A A Marcos
ARAndré C Romano
André C Romano
HNHeloisa Nascimento
Heloisa Nascimento
RBRubens Belfort
Rubens Belfort

8 July 2020 in International Journal of Retina and Vitreous
Verified
Journal Article
Open access
PDF file
JDJoão Rafael de Oliveira Dias
João Rafael de Oliveira Dias
CCCamila Campelo
Camila Campelo
ENEduardo Amorim Novais
Eduardo Amorim Novais
GAGabriel Andrade
Gabriel Andrade
PMPaula Marinho
Paula Marinho
RBRubens Belfort
Rubens Belfort
Background: Ocular toxoplasmosis is one of the most common causes of intraocular inflammation and posterior uveitis in immunocompetent patients. This paper aims to investigate swept-source optical coherence tomography angiography (SS-OCTA) findings in eyes with active toxoplasmic retinochoroiditis. Methods: This case series was conducted from November 2017 through October 2019 in two Brazilian centers. 15 eyes of 15 patients with active toxoplasmic retinochoroiditis were included, and were imaged at baseline and after at least 4 weeks of follow-up. All patients underwent ophthalmic examinations and multimodal imaging including SS-OCT and SS-OCTA before and after treatment of ocular toxoplasmosis. The differential diagnoses included toxoplasmosis, syphilis, and human immunodeficiency virus, which were eliminated through serologic and clinical evaluations. Results: All 15 patients presented with positive anti-Toxoplasma gondii immunoglobulin G titers and three also presented with positive anti-T. gondii immunoglobulin M titers. The mean age at examination was 32.4 years ± 12.7 years (range 15–59 years). Sixty percent of the patients were female. In all eyes, the inner retinal layers were abnormally hyperreflective with full-thickness disorganization of the retinal reflective layers at the site of the active toxoplasmic retinochoroiditis. At baseline, 80% of eyes had focal choroidal thickening beneath the retinitis area, and all eyes had a choroidal hyporeflective signal. Before treatment, SS-OCTA showed no OCTA decorrelation signal next to the lesion site in all eyes, and flow signal improvement was noticed after treatment. Three eyes presented with intraretinal vascular abnormalities during follow-up. SS-OCTA showed retinal neovascularization in one patient and a presumed subclinical choroidal neovascular membrane in another patient. Conclusions: SS-OCT and SS-OCTA are useful for assessing unexpected structural and vascular retinal and choroidal changes in active and post-treatment toxoplasmic retinochoroiditis and these findings are useful for clinical practice.

7 October 2019 in International Journal of Retina and Vitreous
Verified
Journal Article
Open access
PDF file
PMPaula M. Marinho
Paula M. Marinho
HNHeloisa Nascimento
Heloisa Nascimento
ARAndre Romano
Andre Romano
CMCristina Muccioli
Cristina Muccioli
RBRubens Belfort
Rubens Belfort
Background: With increasing incidence of yellow fever, mass campaign vaccinations are underway and little ophthalmological alterations have been reported in literature, specially regarding non-combined vaccines. Case presentation: We report the case of a patient with no previous ocular or systemic diseases whom received a single dose of yellow fever vaccination and developed haematological, hepatic and renal alterations progressing with a later onset bilateral asymmetric diffuse uveitis. Ophthalmological findings included fine keratic precipitates scattered throughout the cornea and mild vitritis. Multimodal evaluation showed subtle puntiform choriocapillaris changes with decreased vascular density associated. The patient had a good visual outcome after mild oral prednisone dose, but the image findings have not presented remission. Conclusions: Clinicians should be aware of clinical and subclinical ocular manifestations such as subtle puntiform choriocapillaris changes as possible vaccine-related adverse events with potential to impact vision.

12 May 2021 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
PMPaula M. Marinho
Paula M. Marinho
AMAlléxya A. A. Marcos
Alléxya A. A. Marcos
ABAna M. C. Branco
Ana M. C. Branco
ARAndré C. Romano
André C. Romano
VSVictoria Sakamoto
Victoria Sakamoto
HNHeloisa Moraes Do Nascimento
Heloisa Moraes Do Nascimento
The main purpose of this study was to investigate ocular clinical findings in patients with confirmed COVID-19 infection, of various levels of disease severity, who required mechanical ventilation and admission to intensive care units or specialized wards. Longitudinal, observational study conducted from March 2020 to June 2020. Color fundus and red-free photography were performed in both eyes following pupillary dilation. 104 participants were recruited from 2 different centers: 60 (58%) from the Hospital Municipal de Barueri intensive care unit (ICU) and 44 (42%) from specialized wards for patients with COVID-19 at the Hospital São Paulo. 21.9% presented with eye lesions, in 3% these lesions were vision compromising. Our results have shown similar rate of intraocular lesions in patients in both the ward or intensive care unit, regardless of medication use, including anticoagulant drugs.

4 June 2014 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
ISIzabella Picinin Safe
Izabella Picinin Safe
VOVictor Costa Morais de Oliveira
Victor Costa Morais de Oliveira
PMPaula Marques Marinho
Paula Marques Marinho
MLMarcus Vinicius Lacerda
Marcus Vinicius Lacerda
MDMárcia Melo Damian
Márcia Melo Damian

1 May 2021 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
DMDiogo Gonçalves dos Santos Martins
Diogo Gonçalves dos Santos Martins
TMThomaz Gonçalves dos Santos Martins
Thomaz Gonçalves dos Santos Martins
PMPaula Marinho
Paula Marinho
PSPaulo Schor
Paulo Schor
BACKGROUND: The new coronavirus of 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally and has repercussions within ophthalmological care. It has caused ocular manifestations in some patients, which can spread through eye secretions. OBJECTIVES: The purpose of this review was to summarize the currently available evidence on COVID-19 with regard to its implications for ophthalmology. DESIGN AND SETTING: Narrative review developed by a research group at Universidade Federal de Sao Paulo (UNIFESP), Sao Paulo (SP), Brazil, and at Ludwig-Maximilians-Universitat, Munich, Germany. METHODS: We searched the literature on the repercussions of COVID-19 within ophthalmological care, using the MEDLINE and LILACS databases, with the keywords "COVID-19", "ophthalmology" and "coronavirus", from January 1, 2020, to March 27, 2021. Clinical trials, meta-analysis, randomized controlled trials, reviews and systematic reviews were identified. RESULTS: We retrieved 884 references, of which 42 were considered eligible for intensive review and critical analysis. Most of the studies selected reported the evidence regarding COVID-19 and its implications for ophthalmology. CONCLUSIONS: Knowledge of eye symptoms and ocular transmission of the virus remains incomplete. New clinical trials with larger numbers of patients may answer these questions in the future. Moreover, positively, implementation of innovative changes in medicine such as telemedicine and artificial intelligence may assist in diagnosing eye diseases and in training and education for students.